On June 24, 2017, Hogan Lovells attorneys Xin Tao (Washington DC Office) and Liang Xu (Beijing Office) spoke at the 15th Annual Conference of the Sino-American Pharmaceutical Professionals Association – Greater Philadelphia’s annual conference. Mr. Tao presented on the “Biosimilar Exclusivity and Interchangeability: A Legal Primer” for both innovators and biosimilar applicants. Mr. Liang presented on “Deal Structure and Legal Considerations” for cross-border life science transactions.
This event drew over 1,000 people from both the Chinese and U.S. pharmaceutical industry. Link to the event is available here.